Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term

HealthEquity (HQY), a healthcare account management provider, is highlighted by Zacks for its strong momentum, featuring a VGM Score of A and a Momentum Style Score of B. This is underscored by a 9.8% share price increase over the past four weeks and recent upward revisions to fiscal 2026 earnings estimates by five analysts, pushing the Zacks Consensus Estimate to $3.84 per share, alongside an average earnings surprise of +11.1%. Despite a Zacks Rank #3 (Hold), these factors position HQY as a stock of interest for momentum-focused investors.

Analysis

HealthEquity (HQY) is demonstrating strong momentum indicators, underpinned by both market performance and positive analyst sentiment. The company's shares have appreciated 9.8% over the past four weeks, a trend that aligns with its 'B' grade for Momentum in the Zacks Style Score system. This is further supported by fundamental developments, as five analysts have revised fiscal 2026 earnings estimates upward within the last 60 days. This collective revision has lifted the Zacks Consensus Estimate for FY2026 by $0.11 to $3.84 per share. Historically, the company has a track record of outperformance, with an average positive earnings surprise of 11.1%. Despite these bullish signals and a top-tier composite 'A' VGM score, HQY currently holds a Zacks Rank of #3 (Hold). This neutral rating presents a notable contrast to the positive momentum factors, suggesting that while near-term trends are favorable, the broader outlook captured by the rank may warrant a more balanced view.

Key Decisions for Investors

• Momentum-oriented investors may find HQY attractive for a tactical position given its 9.8% price increase, positive earnings revisions, and strong style scores.
• Investors should exercise some caution due to the conflicting signals of a neutral #3 (Hold) rank versus the strong momentum indicators, warranting a deeper dive into valuation or potential sector-wide headwinds not detailed in the article.
• Monitor the trend in earnings estimate revisions for fiscal 2026, as continued upward adjustments could be a catalyst for a stock re-rating and are a key driver of the current positive sentiment.